Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies

The level of PD-L1 expression in immunohistochemistry (IHC) assays is a key biomarker for the identification of Non-Small-Cell-Lung-Cancer (NSCLC) patients that may respond to anti PD-1/PD-L1 treatments. The quantification of PD-L1 expression currently includes the visual estimation by a pathologist...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapil, Ansh, Meier, Armin, Zuraw, Aleksandra, Steele, Keith E., Rebelatto, Marlon C., Schmidt, Günter, Brieu, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255873/
https://www.ncbi.nlm.nih.gov/pubmed/30478349
http://dx.doi.org/10.1038/s41598-018-35501-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255873/
https://www.ncbi.nlm.nih.gov/pubmed/30478349
http://dx.doi.org/10.1038/s41598-018-35501-5

Ejemplares similares